Nantes University Hospital
๐ซ๐ทFrance
- Country
- ๐ซ๐ทFrance
- Ownership
- Private
- Established
- 1503-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.chu-nantes.fr
Indications and Interest of US-guided Synovial Biopsies Performed in Clinical Practice
Completed
- Conditions
- Arthritis
- First Posted Date
- 2018-01-31
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 201
- Registration Number
- NCT03417167
- Locations
- ๐ซ๐ท
CHU de Nancy, Nancy, France
๐ซ๐ทChu d'Angers, Angers, France
๐ซ๐ทChu de Dijon, Dijon, France
Oral Quality of Life
Completed
- Conditions
- Odontalgia
- First Posted Date
- 2018-01-29
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 59
- Registration Number
- NCT03413475
- Locations
- ๐ซ๐ท
Hospital University of Nantes, Nantes, France
Lung Ultrasound for Community-acquired Pneumonia Diagnosis in Emergency Medicine
Completed
- Conditions
- Community Acquired Pneumonia
- First Posted Date
- 2018-01-26
- Last Posted Date
- 2021-03-19
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT03411824
- Locations
- ๐ซ๐ท
Nantes University Hospital, Nantes, France
๐ซ๐ทSaint-Nazaire Hospital, Saint-Nazaire, France
๐ซ๐ทLa Roche Sur Yon Hospital, La Roche-sur-Yon, France
Interest of a Vaginal Swab in Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth
Completed
- Conditions
- Preterm LaborPreterm Birth
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 341
- Registration Number
- NCT03401255
- Locations
- ๐ซ๐ท
Nantes University Hospital, Nantes, France
๐ซ๐ทLa Roche-sur-yon University Hospital, La Roche-sur-Yon, France
Extubation Strategies in Neuro-Intensive Care Unit Patients and Associations With Outcome.
Completed
- Conditions
- Brain Injuries
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 1750
- Registration Number
- NCT03400904
- Locations
- ๐ฎ๐ณ
Varanasi BHU Hospital, Varanasi, India
๐ฎ๐นUniversity of Genes, Genova, Italy
๐ซ๐ทNantes University Hospital, Nantes, France
Prevalence of ESBL and CPE in French Nursing Homes
Completed
- Conditions
- Enterobacteriaceae Infections
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 734
- Registration Number
- NCT03401242
- Locations
- ๐ซ๐ท
Nantes University Hospital, Nantes, France
Quantification of Nerve Stiffness in Neuropathies
Not Applicable
- Conditions
- Anti-MAG NeuropathyCharcot-Marie-Tooth Disease, Type IAChronic Inflammatory Demyelinating Polyneuropathy
- Interventions
- Other: elastography measurements
- First Posted Date
- 2018-01-11
- Last Posted Date
- 2018-03-02
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT03397303
- Locations
- ๐ซ๐ท
Univeristy of Nantes, Nantes, France
Virtual Reality and Brain Stimulation, an Experiential Approach
Not Applicable
Completed
- Conditions
- Acrophobia
- Interventions
- Device: VR + sham brain stimulationDevice: VR + active brain stimulation
- First Posted Date
- 2018-01-02
- Last Posted Date
- 2018-07-30
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 28
- Registration Number
- NCT03387254
- Locations
- ๐ซ๐ท
University Hospital, Nantes, France
CIQTP Prolongation : Role and Mechanism in Sudden Cardiac Death
Completed
- Conditions
- Sudden Cardiac Death
- Interventions
- Other: Non interventional study
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 394
- Registration Number
- NCT03387072
- Locations
- ๐ซ๐ท
Rennes University Hospital, Rennes, France
๐ซ๐ทNantes University Hospital, Nantes, France
๐ซ๐ทTours University Hospital, Tours, France
Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients
Phase 1
- Conditions
- Melanoma
- Interventions
- Drug: TIL + IL-2 + Nivolumab
- First Posted Date
- 2017-12-15
- Last Posted Date
- 2022-05-06
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 11
- Registration Number
- NCT03374839
- Locations
- ๐ซ๐ท
Nantes University Hospital, Nantes, France
ยฉ Copyright 2025. All Rights Reserved by MedPath